There is an increasing role for biological markers (biomarkers) in the understanding and
diagnosis of neurodegenerative disorders. The application of imaging biomarkers specifically …

11 C-BU99008 is a novel positron emission tomography (PET) tracer that enables selective
imaging of astrocyte reactivity in vivo. To explore astrocyte reactivity associated with …

Cell stress and impaired oxidative phosphorylation are central to mechanisms of synaptic loss
and neurodegeneration in the cellular pathology of Alzheimer’s disease (AD). In this study…

Post mortem neuropathology suggests that astrocyte reactivity may play a significant role in
neurodegeneration in Alzheimer’s disease. We explored this in vivo using multimodal PET …

Importance Identifying brain regions associated with risk factors for dementia could guide
mechanistic understanding of risk factors associated with Alzheimer disease (AD). Objectives …

BackgroundPhase three trials of the monoclonal antibodies lecanemab and donanemab,
which target brain amyloid, have reported statistically significant differences in clinical end-…

Background We measured whole body distribution of 11 C-BU99008, a new PET biomarker
for non-invasive identification of the imidazoline 2 binding site. The purpose of this phase I …

Background Amyloid-β (Aβ) PET has emerged as clinically useful for more accurate diagnosis
of patients with cognitive decline. Aβ deposition is a necessary cause or response to the …

Cell stress and impaired oxidative phosphorylation are central to mechanisms of synaptic
loss and neurodegeneration in the cellular pathology of Alzheimer’s disease (AD). We …

Introduction: The novel South London and Maudsley Brain Health Clinic (SLaM BHC) leverages
advances in remote consultations and biomarkers to provide a timely, cost-efficient and …